Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
71,979,588
-
Shares change
-
+2,297,852
-
Total reported value, excl. options
-
$2,669,848,746
-
Value change
-
+$83,550,338
-
Put/Call ratio
-
59%
-
Number of buys
-
88
-
Number of sells
-
-96
-
Price
-
$37.09
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2020
251 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2020.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,979,588 shares
of 100,740,741 outstanding shares and own 71% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (9,228,020 shares), BlackRock Inc. (7,897,602 shares), VANGUARD GROUP INC (7,564,946 shares), FMR LLC (5,901,659 shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3,955,787 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,627,397 shares), JANUS HENDERSON GROUP PLC (3,399,684 shares), STATE STREET CORP (3,183,655 shares), JPMORGAN CHASE & CO (2,068,574 shares), and FARALLON CAPITAL MANAGEMENT LLC (1,900,000 shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.